COMMUNIQUÉ DE PRESSE publié le 30/08/2023 à 14:30, il y a 1 année The Science Times Publishes Article About Jaguar Health's Focus on Developing Crofelemer for Two Rare Disease Indications
COMMUNIQUÉ DE PRESSE publié le 28/08/2023 à 14:30, il y a 1 année Jaguar Health to Present September 7 at Emerging Growth Conference and at the September 11-13 H.C. Wainwright Annual Global Investment Conference
COMMUNIQUÉ DE PRESSE publié le 24/08/2023 à 13:00, il y a 1 année Jaguar Health Engages B2i Digital to Deploy Cutting-Edge Investor Engagement Campaign
COMMUNIQUÉ DE PRESSE publié le 17/08/2023 à 14:30, il y a 1 année 1 mois Napo Pharmaceuticals, a Jaguar Health Family Company, Reports Completion of Last Patient Last Visit for its Pivotal Phase 3 OnTarget Trial of Crofelemer for Preventive Treatment of Cancer Therapy-Related Diarrhea
COMMUNIQUÉ DE PRESSE publié le 16/08/2023 à 14:30, il y a 1 année 1 mois Napo Pharmaceuticals Surveys of Neurologists, Patients, and Caregivers Regarding Amyotrophic Lateral Sclerosis (ALS) Treatment Indicate Real World Burden of Diarrhea and Potential Treatment Interruption
COMMUNIQUÉ DE PRESSE publié le 14/08/2023 à 14:00, il y a 1 année 1 mois Jaguar Health Reports Second Quarter 2023 Financial Results
COMMUNIQUÉ DE PRESSE publié le 10/08/2023 à 14:30, il y a 1 année 1 mois Jaguar Health to Hold Investor Webcast Monday, August 14th at 8:30 AM EDT Regarding Q2 2023 Financials & Corporate Updates
COMMUNIQUÉ DE PRESSE publié le 09/08/2023 à 14:30, il y a 1 année 1 mois Napo Pharmaceuticals, a Jaguar Health Family Company, Submits Funding Application to BARDA for Development of NP-300 Drug Candidate for Cholera-Related Diarrhea
COMMUNIQUÉ DE PRESSE publié le 08/08/2023 à 14:30, il y a 1 année 1 mois Napo Pharmaceuticals, a Jaguar Health Company, Announces Activation by FDA of Investigational New Drug (IND) Application for Crofelemer for Treatment of Microvillus Inclusion Disease
COMMUNIQUÉ DE PRESSE publié le 07/08/2023 à 14:30, il y a 1 année 1 mois Independent Study Published in Clinical Breast Cancer Shows Activity of Jaguar Health's Crofelemer for Neratinib-induced Diarrhea
Publié le 19/09/2024 à 17:45, il y a 13 heures 53 minutes Gimv draagt helft van participatie in Infravest over aan WorxInvest (communicatie in toepassing van artikel 7:97 WVV)
Publié le 19/09/2024 à 17:45, il y a 13 heures 53 minutes Gimv sells half of participation in Infravest to WorxInvest (communication pursuant to article 7:97 BCAC)
Publié le 19/09/2024 à 17:45, il y a 13 heures 53 minutes Gimv sells half of participation in Infravest to WorxInvest (communication pursuant to article 7:97 BCAC)
Publié le 20/09/2024 à 02:00, il y a 5 heures 38 minutes Academy of Math and Science Celebrates Hispanic Heritage Month
Publié le 19/09/2024 à 23:15, il y a 8 heures 23 minutes Cypher Metaverse Inc. Announces Second Closing of Financing
Publié le 19/09/2024 à 23:00, il y a 8 heures 38 minutes WestJet Partners with FLYHT and NOAA to Improve Weather Forecasting in North America
Publié le 19/09/2024 à 23:00, il y a 8 heures 38 minutes Cerrado Files NI 43-101 Preliminary Economic Assessment Technical Report and Mineral Resource Estimate for The Minera Don Nicolas Mine in Santa Cruz, Argentina
Publié le 20/09/2024 à 07:00, il y a 37 minutes Mister Spex SE: Extraordinary General Meeting adopts all resolutions as proposed by the Company’s Boards
Publié le 20/09/2024 à 06:26, il y a 1 heure 11 minutes Original-Research: www.warimpex.com (von East Value Research GmbH ):
Publié le 20/09/2024 à 05:15, il y a 2 heures 22 minutes Alibaba Cloud Empowers Customers and Partners with its Proven Large Models and High-Performance Infrastructure
Publié le 19/09/2024 à 21:09, il y a 10 heures 28 minutes EQS-Adhoc: Mercedes-Benz Group AG adjusts full-year guidance for the year 2024 based on current market outlook
Publié le 19/09/2024 à 18:44, il y a 12 heures 53 minutes Fuller, Smith & Turner PLC: Transaction in own shares